Evidence map›Paper›PMID 20664519›Full record

ReviewNature reviews. Gastroenterology & hepatology2010

Probiotics and the gut microbiota in intestinal health and disease.

Mélanie G Gareau, Philip M Sherman, W Allan Walker

Abstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 397 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
397citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

397 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Nutrients · 2022
    Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Prebiotics and probiotics in animal nutrition: implications for food safety, sustainability, and circular production systems.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Review
  15. Article
  16. Foods (Basel, Switzerland) · 2026
    Article
  17. The Gut in Early Life-Postnatal Challenges.Children (Basel, Switzerland) · 2026
    Review
  18. Impact of the defined Oligo-MMScientific reports · 2026
    Article
  19. Review
  20. Article

337 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mélanie G GareauCell Biology Program, Research Institute, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON M5G 1X8, Canada.
Philip M Sherman
W Allan Walker

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Alessio Fasano · 1994 to 2026
$31.6M
Xenograft and Isograft CoreP01DK033506 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MCCORMICK, BETH A · 1986 to 2015
$24.2M
EFFECT OF COLOSTRUM ON GUT MATURATION AND HOST DEFENSER01HD012437 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, W ALLAN · 1989 to 2013
$2.0M
Ontogeny of the intestinal mucosal barrier and NECR01DK070260 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, W ALLAN · 2005 to 2009
$1.8M
CIHRNICHD NIH HHS R01 HD012437NIDDK NIH HHS P01 DK033506NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R01 DK070260
6 · The paper itself

Abstract

The use of probiotics is increasing in popularity for both the prevention and treatment of a variety of diseases. While a growing number of well-conducted, prospective, randomized, controlled, clinical trials are emerging and investigations of underlying mechanisms of action are being undertaken, questions remain with respect to the specific immune and physiological effects of probiotics in health and disease. This Review considers recent advances in clinical trials of probiotics for intestinal disorders in both adult and pediatric populations. An overview of recent in vitro and in vivo research related to potential mechanisms of action of various probiotic formulations is also considered.

Indexed as

DiarrheaGastrointestinal DiseasesGastrointestinal TractHumansInflammatory Bowel DiseasesProbiotics

Identifiers

PMID20664519
PMCPMC4748966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.